To explore how FASN inhibition affects anti-tumor immune response in vivo, we analyzed tumor-infiltrating immune cells in ID8 mice treated with FASN inhibitor cerulenin, a small molecule antibiotic. The gene discussed is FASN; the disease is neoplasm.